热门资讯> 正文

GH Research定价1.175亿美元的股票发行

2026-04-29 20:41

COMPASS Pathways Plc Sponsored ADR(CMPS) 0

GH Research said on Wednesday it priced an underwritten U.S. offering of 6.53M ordinary shares at $18 each, for gross proceeds of about $117.5M
The company is selling all of the shares in the offering, which is expected to close on April 30.
The transaction was initiated by Lynx1 Capital Management, with participation from Deep Track Capital and Foresite Capital.
Stifel, Cantor Fitzgerald and RBC Capital Markets are acting as joint book-running managers. Canaccord Genuity and Citizens Capital Markets are co-lead managers.
Shares down -1% premarket.

More on GH Research

GH Research: WH Decision On Psychedelics To Treat Depression Makes Bull Case
GH Research FY25 Results: Strong Cash Position As GH001 Advances Toward Phase 3
Cybin stands out as the most undervalued psychedelic stock as Trump signs on faster PTSD research
Psychedelic stocks rally after Trump orders faster PTSD research; Compass Pathways, Atai lead gains
Seeking Alpha’s Quant Rating on GH Research

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。